Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4-IgG-Positive NMOSD.

Lin J, Xue B, Xie D, Li J, Pan J, Zhu L, Tong Q, Lin J, Zhu R, Zhang X, et al.

Ann Clin Transl Neurol. 2026 Apr 24. PMID: 42028704. Abstract